Chemical Carcinogenesis
Exposure to the chemical compounds that can induce varying effects, ranging from instant mortality to a gradual process of progression of carcinogenesis is called as Chemical Carcinogenesis. The stages involved in carcinogenesis normally are initiation, promotion and progression which are characterised by structural and functional modifications and result from genetic and/or epigenetic alterations/ Changes. These genetic modifications include mutations in genes that control cell proliferation, cell death and DNA repair and proto-oncogenes and tumour suppressing genes. The epigenetic factors, which are considered as being non-genetic in character, can also contribute to carcinogenesis via epigenetic mechanisms which silence gene expression
- Genetic and epigenetic
- DNA damage
- Genome instability
Related Conference of Chemical Carcinogenesis
20th International Conference on Environmental Toxicology and Ecological Risk Assessment
7th International Conference on Global Toxicology and Risk Assessment
22nd International Conference on Clinical Toxicology and Pharmacology
5th International Conference on Clinical Pharmacology and Toxicology
Chemical Carcinogenesis Conference Speakers
Recommended Sessions
- Applications of Toxicology
- Cardiovascular Toxicology
- Chemical Carcinogenesis
- Clinical Toxicology
- Environmental Toxicology
- Forensic Toxicology
- Genetic Toxicology
- Immunotoxicology
- Molecular Toxicology
- Neurotoxicology
- Reproductive and Developmental Toxicology
- Systemic Toxicology
- Toxicity Testing`
- Toxicology and Risk Assessment (TRA)
- Toxicology study in Effects on Liver and Kidney
- Toxicology study in Haemostasis
- Toxicopathology
Related Journals
Are you interested in
- Analytical Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Aquatic Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Behavior toxicology - clinicalpharmacology2023 (Spain)
- Behavior Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Bio-availability - clinicalpharmacology2023 (Spain)
- Bio-equivalence - clinicalpharmacology2023 (Spain)
- Biochemical Pharmacology - clinicalpharmacology2023 (Spain)
- Biologic drugs - clinicalpharmacology2023 (Spain)
- Chemical Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Clinical and medical pharmacology - clinicalpharmacology2023 (Spain)
- Clinical Pharmacological - GLOBAL TOXICOLOGY 2023 (Portugal)
- Drug discovery and Drug development - clinicalpharmacology2023 (Spain)
- Drug Safety - clinicalpharmacology2023 (Spain)
- Ecological Risk Assessment - GLOBAL TOXICOLOGY 2023 (Portugal)
- Environmental Toxicology - clinicalpharmacology2023 (Spain)
- Experimental and Toxicologic Pathology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Genotoxicity - clinicalpharmacology2023 (Spain)
- Human Health Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Immuno Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- In Vitro Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Medical Development and Safety Testing - GLOBAL TOXICOLOGY 2023 (Portugal)
- Microbial Toxicology - clinicalpharmacology2023 (Spain)
- Microbial Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Molecular Pharmacology - clinicalpharmacology2023 (Spain)
- Nano toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Nanomedicine and Nanotechnology - clinicalpharmacology2023 (Spain)
- Pharmaceutical biotechnology - clinicalpharmacology2023 (Spain)
- Pharmacodynamics - clinicalpharmacology2023 (Spain)
- Pharmacogenomics - clinicalpharmacology2023 (Spain)
- Pharmacokinetics - clinicalpharmacology2023 (Spain)
- Pharmacology - GLOBAL TOXICOLOGY 2023 (Portugal)
- Pharmacology and Toxicology - clinicalpharmacology2023 (Spain)
- Pharmacovigilance - clinicalpharmacology2023 (Spain)
- Route of administration - clinicalpharmacology2023 (Spain)
- Toxic genomic - GLOBAL TOXICOLOGY 2023 (Portugal)
- Toxicology - GLOBAL TOXICOLOGY 2023 (Portugal)